Format

Send to

Choose Destination
Methods Mol Biol. 2011;728:179-94. doi: 10.1007/978-1-61779-068-3_11.

Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.

Author information

1
Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Abstract

Targeted mass spectrometry using selected reaction monitoring (SRM) has emerged as the method of choice for the validation in blood serum, plasma, or other clinically relevant specimens of biomarker candidates arising from comparative proteomics or other discovery strategies. Here, we describe a method in which N-glycosites are selectively enriched from biological specimens by solid phase capture and PNGase F release, and then analyzed by SRM. Focusing the highly sensitive targeted mass spectrometry method on a subproteome enriched for secreted and shed proteins reproducibly identifies and quantifies such proteins in serum and plasma at the low nanogram per milliliter (ng/mL) concentration range. This protocol is intended to give an introduction to SRM-based targeted mass spectrometry with a special focus on the validation of biomarker candidates.

PMID:
21468948
DOI:
10.1007/978-1-61779-068-3_11
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center